NEW YORK (GenomeWeb News) – Caliper Life Sciences will use SRU Biosystems' screening platform to offer new functional assays through its Discovery and Alliances services, SRU said today.
Under the agreement, Caliper will use SRU's label-free BIND technology for high-throughput screening and profiling for cell-based and biochemical assays.
The BIND platform can be used to access new hits and lead molecules, including compounds that undergo G-protein switching, non-G coupled pathways, and receptor desensitization, as well as inverse and partial agonists. The technology also can be used for receptor profiling on native cells, SRU said.
Caliper plans to incorporate SRU's platform in contract services it offers to the biotechnology and pharmaceutical research communities.
Financial terms of the agreement were not released.